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Abstract 
Lineage trees have frequently been drawn to illustrate diversification, via somatic hypermutation 
(SHM), of immunoglobulin variable-region (IGV) genes. In order to extract more information from IGV 
sequences, we developed a novel mathematical method for analyzing the graphical properties of IgV 
gene lineage trees, allowing quantification of the differences between the dynamics of SHM and 
antigen-driven selection in different lymphoid tissues, species, and disease situations. Here, we 
investigated trees generated from published IGV sequence data from B cell clones participating in 
autoimmune responses in patients with Myasthenia Gravis (MG), Rheumatoid Arthritis (RA), and 
Sjögren’s Syndrome (SS). At present, as no standards exist for cell sampling and sequence extraction 
methods, data obtained by different research groups from two studies of the same disease often vary 
considerably. Nevertheless, based on comparisons of data groups within individual studies, we show 
here that lineage trees from different individual patients are often similar and can be grouped 
together, as can trees from two different tissues in the same patient, and even from IgG- and IgA- 
expressing B cell clones. Additionally, lineage trees from most studies reflect the chronic character of 
autoimmune diseases.  
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Take-home messages 
• IGV lineage trees contain useful quantitative information on the dynamics of the humoral immune 
response under various conditions. 
• Lineage trees from B cell clones participating in autoimmune diseases (MG, RA, and SS) are often 
larger (in terms of overall number of nodes) than those from normal human germinal centers (GCs), 
most probably due to the long-term ongoing IGV diversification in these clones.  
• More detailed analyses are hindered by the fact that data obtained by independent research groups 
often differ greatly, due to variability in cell sampling and sequence extraction methods, and possibly 
also to differences in disease duration by the time of sampling, and other patient or treatment factors.  
• Lineage trees from IgA- and IgG- expressing B cell clones from the same patient do not significantly 
differ. Neither do lineage trees from different tissues in the same patient, e.g. labial salivary glands 
and lymph node, or parotid gland and peripheral blood, in the same SS patients.   
Introduction
The generation of “lineage trees" (also called “dendrograms” or “pedigrees”) to visualize the lineage 
relationships of B cell mutants in the GCs has been used in the past to confirm the role of the GC as 
the location of somatic hypermutation [1,2,3], to identify lineage relationships between cells from 
independent GCs [4] or different tissues  [5,6] and from additional processes of diversification such as 
gene conversion in the rabbit [7]. The experimentally generated lineage trees reflect the multiple 
rounds of mutation for each germline IGV that participates in the primary response. We have 
suggested that much information about the dynamics of antigen-driven clonal selection during the 
immune response is contained in the shape of lineage trees deduced from the final responding clones 
[8]. For example, trees generated from clones during the peak of the primary response are much 
more branched or ``bushy" [9], but trees become less branched as the response progresses [10]. The 
“pruned" shape of these trees has been cited as evidence of the destructive nature of somatic 
hypermutation. Other examples of lineage trees drawn to illustrate various aspects of the germinal 
center reaction, or differences in this reaction under varying circumstances, abound in the literature. 
In the above-reviewed studies, however, lineage tree classification has been based only on a 
qualitative, intuitive assessment of the most obvious shape characteristics, looking only at a few trees 
at a time.  
 
In order to extract the quantitative information embedded in the shape characteristics of lineage trees, 
we developed a rigorous computer-aided algorithm for measuring lineage tree graphical properties 
(Figure 1 and Table 1), and have found correlations between these measures and the dynamical 
parameters of the GC response that generated the trees [11,12]. We have applied this method to 
study age-related differences in the humoral immune response in humans, with the surprising result 
that the GC reaction dynamics – and the effects of aging on these dynamics – differ between GCs 
taken from different tissues [13, 14]. Applying this method to lineage tree data from Ig primary and 
secondary diversification processes in rabbits and chickens, which use gene conversion as well as 
SHM during both primary and secondary diversification [7], has highlighted the unique characteristics 
of the genetic and selective processes driving the formation of the Ig repertoire in these two species. 
In our most recent study [15], we have analyzed the bone marrow (BM) and peripheral blood (PB) 
clonal populations from patients with Light Chain Amyloidosis (AL) and multiple myeloma for evidence 
of ongoing B cell diversification. We detected the presence of clonally-related populations within the 
BM and PB, indicative of ongoing mutation. The clonal trees for these populations differed from those 
of normal controls. Differences in tree shape characteristics have also been observed in our 
preliminary analyses of IGV from several B cell malignancies (Zuckerman et al, unpublished).  
 
Quantitative analysis of the shape properties of IGV lineage trees thus provides novel insights into the 
mechanisms of normal and malignant B cell clonal evolution. Our aim here is to broaden the 
application scope of lineage tree analysis towards other situations where IGV are diversified. In the 
present paper we review the results of our comparative analyses of IGV lineage trees from several  
autoimmune diseases, in which GC-like areas exist within the afflicted tissue or organ, composed 
mostly of activated B cells undergoing somatic hypermutation and (presumably antigen-driven) 
selection [16, 17, 18]. It has been suggested [16] that perhaps the onset of tolerance breakdown 
leading to autoimmune pathology is a result of B cell expansion in GCs outside the secondary 
lymphoid structures.  These ectopic GCs may lack the normal protective mechanisms preventing 
expansion of auto-reactive mutants, thereby allowing an anti-self reaction to persist.  
 
We have analyzed data from studies on patients with Myasthenia Gravis (MG), Rheumatoid Arthritis 
(RA), and Sjögren’s Syndrome (SS). Different research groups use different methods of cell sampling 
and of sequence data extraction, there are also differences in the disease state and treatment of 
patients.  These differences cause difficulties in making comparisons across different data sets. 
Nevertheless, we were able to identify several similarities and differences between data from different 
tissues, B cell isotypes and disease groups, as discussed below. 
 
Methods 
Source of data for analysis.   The data used in this study were collected by a thorough literature 
search for IGV sequences from patients with autoimmune disease, this yielded the published studies 
listed in Table 2.  
 
Lineage tree generation.  In some of the studies we used [17-19], lineage trees were already drawn. 
In others, only sequences were published [20-23]; in these cases, we identified germline genes by 
alignment with published human IGV [24], and trees were generated using a computer program 
developed by us (M. Barak et al, unpublished), which is specifically tailored to deal with IGV 
sequences.  
 
Tree shape analysis.  A lineage tree is defined, graphically, as a rooted tree where the nodes 
correspond to B cell receptor gene sequences (Figure 1A). For two nodes X and Y, we say that Y is a 
child of X if the sequence corresponding to Y is a mutant of the sequence corresponding to X, which 
differs from X by only one mutation, and is one mutation further than X away from the original 
(germline) gene, that is, the root. Two B cells with identical receptor genes will thus correspond to the 
same node. A lineage tree depicts the maturation process of a B cell clone at a certain moment of 
observation – it consists only of the IG sequences of cells that were sampled at that moment and their 
ancestors back to the root, which were not necessarily sampled at the time of observation. Nodes in 
the tree (Figure 1A) can be either the root node, leaves (end-point sequences), or internal nodes, 
which can be either split nodes (branching points) or pass-through nodes. 
 
The shape of lineage trees is quantified by measuring a number of properties of the graph describing 
the tree. For quite a few of these properties, the maximum, minimum and average values per tree 
may be measured. The complete list of variables measured is given in Table 1, including remarks on 
the meaning and usefulness of each variable. Our tree-measurement computer program reads a tree 
in the adjacency list format [11] and calculates the graphical variables. We intend to create, in the 
near future, a user-friendly interface for this program and make it available on the web for any 
researcher interested in analysis of their lineage trees; for the time being we are willing to analyze 
data sent to us upon request (see http://repertoire.ls.biu.ac.il/TREES for details).  
 
Statistical analysis.  Significance analysis was done using Student's t-test. To correct for the fact 
that we perform multiple comparisons (on 25 different tree properties), we used the FDR method [25]. 
Only differences that were found to be significant after this correction are considered as meaningful in 
our studies.  
 
 
Results
Even when studying the same disease, different research groups use different experimental 
techniques (Table 2), and sometimes include different data groups within a study of particular disease 
(e.g. some of the IGV studied in RA were of different isotypes). Additionally, there may be differences 
caused by the method used for the generation of trees. There is more than one commonly used 
algorithm for generating phylogenetic trees from sequence data [26-29]. Different algorithms, or even 
different implementations of the same basic algorithm in different software packages, generate 
slightly different trees from the same data sets (Mehr et al, unpublished observations). It is not clear a 
priory whether these trees are statistically equivalent in their graphical properties. Hence we have 
made comparisons between all smallest possible groups in the first instance to determine which 
would be appropriate to combine. 
 
We have used only one study of IgV gene diversification in MG, performed by Sims et al [17]. 
However, some lineage trees were generated by the authors [17] and the rest were generated by us 
from additional sequence data, so we first checked whether lineage trees in the two groups differ in 
any of the tree properties we measure. Fortunately, we found that the two MG data groups, 
containing 6 and 7 trees, respectively, do not significantly differ in tree properties, and hence may be 
grouped together.  
 
The RA data was obtained from three separate studies done by different research groups, two using 
microdissection [19,20], and one using mononuclear cells isolated from single cell suspensions [23]. 
A comparison between tree properties from the first two groups yielded p-values smaller than 0.05 for 
only a few variables, and even those differences were insignificant after the FDR correction. In spite 
of this, we do not feel that the two data groups may be grouped together, as the average number of 
nodes (N) in the Gause et al.[20] trees is almost four-fold larger than that of the Kim et al.[19] trees 
(Figure 1B). Many other tree properties, such as the average root-to-leaf path lengths (average 
number of mutations per endpoint sequence), are proportionally larger in the former group’s trees as 
well (Figure 1B). This difference could be due to different experimental methods, as each group’s 
methods vary slightly at all stages of data extraction (sampling, cell labeling, and DNA amplification – 
see Table 2), or to different disease durations at time of extraction, and do not necessarily indicate an 
inherent difference between B cell clone dynamics in these RA patients as would be expected if there 
were differences in disease severity. The first possibility definitely influences the results – although 
the pick size (number of PCR clones sequenced) in each experiment was not given (neither was 
disease duration in most cases), it is obvious that larger trees were observed wherever a large 
number of PCR clones was sequenced, as expected. In the data from Miura et al [23], IgA- and IgG-
expressing B cells from two patients were analyzed separately; however some clones had cells from 
both isotypes, so we grouped them together and named these mixed trees “IgA-IgG”. Upon 
measuring the trees, we found no significant differences between IgA-only, IgG-only, and IgA-IgG 
lineage trees, and hence these groups could be merged. Data from the two patients could also be 
merged as we did not find significant differences between the tree properties from the two patients. 
The single cell extraction method used in this study may have allowed for more cells to be extracted 
and more complete trees to be found; this is suggested by the larger number of leaves, L, and a 
result the number of nodes in these trees is also larger (Figure 1B). Pick size does not explain, 
however, why the number of mutations per sequence (average or max PL) is also so much larger in 
this data group. All in all, we cannot say whether the significantly larger trees in this data group, 
compared to the other two groups, mean that there is an intrinsic difference between B cell clone 
dynamics in the three studies, or are due to methodological differences.    
 
A similar situation applies to the data from SS patients (Figure 1B), where trees in one 
microdissection study [21] were much larger – significantly larger this time – than the trees from a 
second microdissection study [18]. Within the data group in [21] there were sequences extracted from 
two tissues, salivary gland and lymph node. The salivary gland sequences were from two patients. 
The first comparison was thus made between these two patients; the differences between properties 
of trees generated from the sequences of these two patients were not significant, and hence the two 
data sets could be merged. We next compared tree properties in the two different tissues in [21]. The 
two tissue data sets showed no significant differences, and could therefore be also combined into one 
data set. However, when comparing the data from the two research groups [18,21], we found 
significant differences in the overall number of nodes and in 12 (out of 24 measured) other tree 
properties, all of which represent path lengths or parts of paths. A third study [22], which used 
mononuclear cells isolated from single cell suspensions, yielded lineage trees of intermediate sizes 
compared to the above two groups. These data were obtained from two tissue sources, the parotid 
gland and peripheral blood. There was only one significant difference (in minimum DLFSN, see Table 
1) between the two groups, yet the absolute values were similar, hence we treated these two groups 
as one. On the other hand, the maximum and average path lengths significantly differed between the 
Gellrich and Jacobi [21, 22] data; this could not be due to differences in sampling (which can change 
the numbers of leaves found and hence bushiness-related measures, but not the number of 
mutations in individual cells) and hence may be due to either a longer, or a more vigorous, 
proliferation in the Gellrich [23] clones.  
 
Finally, we compared all the above data groups to data from normal human controls, taken either 
from microdissection of normal human GCs [13, 30] or from PBL [15]. What is immediately obvious 
from this comparison (Figure 1B) is that, in all but two of the data groups, lineage trees from 
autoimmune diseases are larger than those from normal immune responses. This is seen in spite of 
the fact that the control data could also come from clones participating in secondary responses. In the 
data groups which did not significantly differ from normal trees, the most likely reasons for this are 
that the relevant B cell clones in these cases had not yet had a chance to diversify significantly by the 
time of sampling. We believe that this difference is due to the chronic nature of autoimmune 
responses, and intend to investigate additional tree properties, to see if more can be learned about 
the dynamics of autoimmune GC reactions using this method.  
 
 
Discussion  
Lineage tree variables depend on the following four factors. The first important factor is the number of 
different sequences within each clone obtained in a given experiment – the “pick size”. This in turn is 
affected by the method of cell collection for DNA analysis, which also influences data resolution [12]. 
The number of distinct endpoint sequences (leaves) will depend on the pick size, and if the sample is 
small, this will also affect the tree’s degree of branching (“bushiness”). The experimental data 
analyzed above was generated by different research groups at different times, using various methods 
to extract DNA sequences from samples of patients in which the disease duration and severity 
probably varied as well. In order to extract meaningful conclusions from such data, it would help if 
future studies use similar methods as much as possible, analyze a larger number of patients per 
study, and always include normal control groups as well. Moreover, the methods of tree generation 
from sequence alignments should also be standardized. Since generating IgV gene trees differs from 
generation of phylogenetic trees of other genes, e.g. evolutionary trees, where the root sequence is 
unknown, and, on the other hand, the trees can be assumed to be binary. Hence we have had to 
create our own program, specifically suited for IgV gene lineage tree generation (M. Barak et al, 
unpublished).  
 
The second factor is the intrinsic potential for improvement via hypermutation possessed by each 
antigen receptor gene – the closer the original receptor is to optimally binding the driving antigen, the 
fewer the mutations that could lead to improvement of binding, and the higher the probability that a 
mutation will be deleterious or reduce the receptor's affinity to the antigen [8].  This was observed in a 
comparison of the response to a high affinity antigen (hen egg lysozyme) and a low affinity antigen 
(duck egg lysozyme) by B-cells expressing the same transgenic antigen receptor [31]. Affinity 
selection was only observed during the response to the low affinity antigen.  This is mostly relevant in 
normal responses; in chronic responses, the GC reaction may go on even when the optimal receptor 
for the driving antigen has already been created.  
 
The third factor or rather set of factors influencing lineage tree shape are the rate and duration of the 
hypermutation process itself. The overall number of mutations will depend on the product of the 
duration of the response (measured e.g. in days), the cells’ probability of division per time unit (e.g. 
per day), and the probability of mutation per base pair per division. We assume that the 
hypermutation rate itself is already maximized, as it is already 106 times faster than normal somatic 
mutation, and is believed to occur by a single common mechanism; hence the overall number of 
nodes (individual mutations) in the tree, or the number of nodes from the root (the unmutated 
germline sequence) to a particular leaf (path length), are interpreted as reflecting the duration of the 
reaction and the cells’ division rate. These two biological parameters probably exert the strongest 
influence on the data we have analyzed above, as demonstrated by the large variability in path 
lengths between groups. 
 
Finally, tree shape is strongly influenced by the stringency of selection operating on the mutating 
cells, as selection “prunes” the trees, hence a tree’s bushiness is interpreted as an inverse measure 
of selection. We have yet to investigate this point in relation to autoimmune disease lineage trees. 
The relative strengths of the two opposing forces – diversification and selection – depend on the 
tissue in which the response occurs, the antigen, and other factors regulating response dynamics 
[12]. Since the absolute values of these rates cannot be directly measured, we study the dependence 
of tree properties on biological rates using computer simulations of humoral response dynamics [12, 
and ongoing work].  
 
It should be noted that it is not known whether all clones in autoimmune ectopic GCs are specific for 
the self-antigen involved in the etiology of the autoimmune disease, or whether these environments 
are generally defective in regulation of B cell selection. In the latter instance there may be many 
irrelevant clones developing alongside the auto-reactive clones of interest. Only the MG data in [17] 
was generated from clones that were identified as being specific for the pathogenic self-antigen 
(acetylcholine receptor, AchR); hence, in the other cases reported here, the data may include both 
disease-specific and non-specific clones.  
 
In summary, we find that lineage trees from B cell clones isolated from patients with autoimmune 
diseases (MG, RA, and SS) are often larger than those from normal human germinal centers (GCs), 
most probably due to the long-term ongoing IGV diversification in these clones. On the other hand, 
lineage trees from IgA- and IgG- expressing B cell clones from the same patient do not significantly 
differ. Neither do lineage trees from different tissues in the same patient, e.g. labial salivary glands 
and lymph node, or parotid gland and peripheral blood, in the same SS patients. More detailed 
analyses, which could supply much information about disease triggering and subsequent dynamics, 
are hindered by the fact that data obtained by independent research groups often differ greatly, due 
to variability in cell sampling and sequence extraction methods, and possibly also to differences in 
disease severity, and other patient or treatment factors.  
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Figure Legend
Figure 1. (A) A sample lineage tree. Nodes in the tree can be either the root node (always the node 
numbered zero in our definition, colored orange), leaves (sequences of cells that had no 
descendants at the time of observation – green nodes), or internal nodes. Internal nodes can be 
either split nodes – those with more than one child (yellow nodes); or pass-through nodes – those 
with exactly one child (white nodes). The trunk is the distance between the root to the first split 
node, which equals 1 in this case. (B) A comparison of the average number of nodes (N), the 
average number of leaves (L), the trunk length (T) and the maximum and average path length 
(MaxPL and AvgPL) in trees from the different experimental data groups. An * indicates p<0.05 in 
the comparison between the AI data group to the Normal GC data; an # indicates p<0.05 in the 
comparison between the AI data group and the Normal PBL data. Normal GC data (N-GC) is taken 
from [13,30], Normal PBL (N-PBL) data is taken from [15]. 
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Tree variable definition Abbreviation Range
Total number of nodes, including the root. Indicates the 
overall tree size. 
N N ∈ [2, ∞) 
Total number of leaves, that is, the number of distinct 
sequences found, for which there were no "descendant" 
sequences. 
L L ∈ [1, N-1] 
Number of internal nodes, that is, nodes that are not root or 
leaves. 
IN IN ∈ [0, N-(L+1)] 
Number of pass-through nodes, that is, internal nodes that 
have only one child. 
PTN PTN ∈ [0, IN] 
Length of tree trunk from root to the first split node, that is, 
the number of mutations shared by all leaves. 
T T ∈ [0, N-1] 
Path length, where a path is defined from the root to a leaf, 
hence PL gives the number of mutations per leaf. Longer 
path lengths (in one group of trees relative to another) thus 
indicate that the cells are dividing more rapidly, and/or have 
a higher mutation rate (per division), and/or that the 
hypermutation process has been going on longer in these 
clones relative to those of the other group.    
PL* PL ∈ [1, N-1] 
Distance from a leaf to the first (closest to root) split node:  
DLFSN(leaf i) =PL(leaf i)-T 
DLFSN* DLFSN ∈ [1, MaxPL] 
Outgoing degree, representing the number of children per 
split node. Minimum and maximum OD are measured over 
split nodes, but if there are no splits (L=1) they both equal 1. 
AvgOD is measured over all nodes, including pass-through 
nodes. AvgOD2 represents the outgoing degree averaged 
only over all split nodes.  
ODs are measured of a tree’s level of branching, or 
“bushiness”, which is interpreted as indicating the rate of 
OD* AvgOD ∈ [1,L] 
MinOD ∈ [1,L]  
MaxOD  ∈ [1,L] 
AvgOD2 ∈ [2,L] 
diversification relative to the strength of the selection forces 
acting on the tree, as selection tends to “prune” the tree (by 
killing cells with disadvantageous mutations) and hence 
reduce its bushiness.  
The root’s outgoing degree, that is, the number of branches 
emerging from the root.  RootD=1⇔ T>0.  
RootD RootD ∈ [1,L] 
Distance between adjacent split nodes, that is, between two 
consecutive splits on the same path. It is an inverse 
measure of bushiness (or a direct measure of the relative 
strength of selection) over the whole tree, hence over the 
whole history of the clone.  
DASN* DASN ∈ [1, N-(L+1)] 
Distance from a leaf to the last (closest to leaf) split node; an 
inverse measure of bushiness (or a direct measure of the 
relative strength of selection) over the recent history of the 
clone. 
DLSN* DLSN ∈ [1,N-1] 
Distance from the root to any split node. DRSN* DRSN ∈ [1, MaxPL] 
 
Table 1. Variables measured on each tree. Situations with no leaves (only a root node exists, that is, 
mutated sequences were not found, in which case N=1 and L=0) are not considered in our analysis. 
*For this variable we measure the maximum, minimum and average values (per tree). 
 
Ref* Disease Tissue # of Patients 
# of 
Trees 
Experimental 
Methods <N>
 
Max L Ig Chain 
Sequences found 
[individual, rearranged 
productive, sequences / 
total sequences 
extracted] 
[17] MG Thymus  13 Micro-dissectioni 65.5 11 
HC 
 
18 B cell clones 
92/216 
[19] RA Synovial Tissue 
2 
(EK, PS) 4 
Micro-
dissectionii 19.7 5 
HC, λLC 
& κLC 
EK: 
VH:13 /40 
κ:8/19 
λ:6/19 
PS: 
VH:9/25 
κ:6/14 
λ:2/2 
[23] RA Synovial Tissue 2 20 
Single cell 
suspensions 346.2 26 HC 
263 IgG cells 
276 IgA cells 
 
[20] 
 
RA Synovial Tissue 2 4 
Micro-
manipulation 
78.4 
 8 HC 63 
PB 5 42.4 12 κLC VκJκ:: 39/79 VλJλ: 54/81  
[22] 
 
SS 
Parotid 
Gland 
1 
8 
Single cell 
suspensions 
59.25 12 λLC & κLC 
VκJκ:: 52/75 
VλJλ: 29/38 
Labial 
salivary 
glands 
10 
 
 
122.5 13 HC 
IL-13/38 
UW-13/14 
  
[21] 
SS 
 Lymph 
nodes 
2 
(IL, UW) 
7 
Dissection 
144 8 HC IL-44/48  
 
[18] SS 
Labial 
salivary 
glands 
2 
(BW, SG) 4 
Micro-
dissection 26 11 HC & LC 
BW-22/27 
SG-43/55 
 
Table 2. Sources of data for analysis. *All trees were generated using our 
algorithm from sequence data, except those in [17-19] in which only trees 
and not sequences were given.   
i  - Serial sections 6-8 µm thick were extracted from 4 GC foci. Cells labeled for 
specifically for AchR as well as for CD20. Two rounds of PCR (35 and 40 cycles) 
performed, second cycle nested.   
ii - 6 µm sections from consecutive sections extracted; In patient EK: 3 sections with 
2 foci. In patient PS: 3 sections with 3 Foci. Sections stained for CD20, and KI-67 
nuclear Ag.  Two rounds of PCR (35 and 40 cycles) performed, second cycle semi-
nested. 
iii - Cells sorted for mononuclear cells. One round of PCR (35 cycles) performed. 
 19
iv - 7 µm sections with 12 infiltrate foci with 50-300 cells per focus were extracted. 
Sections stained for CD20. Two rounds of PCR performed.  
v  - Cells stained for CD19+. Two rounds of PCR (35 cycles each) performed, second 
round nested. 
vi - 2 mm3 section extracted from labial salivary gland, 60 mm3 section extracted from 
lymph node.  PCR (cDNA-35 cycles) performed. On salivary gland, in patient IL, 3 
independent rounds and in patient UW, 2 independent rounds performed. On Lymph 
node 3 independent rounds performed. 
vii - 8  µm sized sections. In patient BW three  serial sections extracted from one 
cluster; In patient SG, 2 serial sections from 2 clusters.  Cells stained for CD20 and 
anti CD3. Two rounds PCR (36 cycles), second round nested 
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